Treatment outcomes of childhood tuberculous meningitis: A systematic review and meta-analysis

The Lancet Infectious Diseases

Volumn 14, Issue 10, 2014, Pages 947-957

  Chiang, Silvia S ^a   Khan, Faiz Ahmad ^b   Milstein, Meredith B ^b   Tolman, Arielle W ^b   Benedetti, Andrea ^c,d   Starke, Jeffrey R ^a   Becerra, Mercedes C ^b,e,f  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e PARTNERS IN HEALTH   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; ETHAMBUTOL; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; CEREBROSPINAL FLUID CULTURE; CHILD DEATH; CHILDHOOD DISEASE; HUMAN; HYDROCEPHALUS; LEUKOCYTOSIS; LYMPHOCYTOSIS; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS; CHILD; DRUG EFFECTS; EARLY DIAGNOSIS; ISOLATION AND PURIFICATION; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; RISK; STATISTICAL MODEL; TUBERCULOSIS, MENINGEAL;

CHILD; EARLY DIAGNOSIS; HUMANS; LIKELIHOOD FUNCTIONS; MYCOBACTERIUM TUBERCULOSIS; RISK; TREATMENT OUTCOME; TUBERCULOSIS, MENINGEAL;

EID: 84908159130     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70852-7     Document Type: Article

References (47)

1. Starke JR Tuberculosis of the central nervous system in children. Semin Pediatr Neurol 1999, 6:318-331.
2. Wolzak NK, Cooke ML, Orth H, van Toorn R The changing profile of pediatric meningitis at a referral centre in Cape Town, South Africa. J Trop Pediatr 2012, 58:491-495.
3. Lincoln EM Tuberculous meningitis in children: with special reference to serous meningitis: tuberculous meningitis. Am Rev Tuberc 1947, 56:75-94.
4. Streptomycin treatment of tuberculous meningitis. Lancet 1948, 251:582-596. Medical Research Council.
5. Lincoln EM, Sordillo SVR, Davies PA Tuberculous meningitis in children: a review of 167 untreated and 74 treated patients with special reference to early diagnosis. J Pediatr 1960, 57:807-823.
6. Guidance for national tuberculosis programmes on the management of tuberculosis in children 2014, WHO, World Health Organization, Geneva, (accessed June 28, 2014). http://tbevidence.org/wp-content/uploads/2014/04/WHO-Guidance-Childhood-TB-2014.pdf, 2nd edn.
7. Van Toorn R, Schaaf HS, Laubscher JA, van Elsland SL, Donald PR, Schoeman JF Short intensified treatment in children with drug-susceptible tuberculous meningitis. Pediatr Infect Dis J 2014, 33:248-252.
8. Donald PR The chemotherapy of tuberculous meningitis in children and adults. Tuberculosis (Edinb) 2010, 90:375-392.
9. Woodfield J, Argent A Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate anti-microbial treatment for tuberculous meningitis?. J Trop Pediatr 2008, 54:220-224.
10. Van Toorn R, Solomons R Update on the diagnosis and management of tuberculous meningitis in children. Semin Pediatr Neurol 2014, 21:12-18.
11. Treatment of tuberculosis: American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR Recomm Rep 2003, 52(RR-11):1-80. Centers for Disease Control and Prevention.
12. Prasad K, Singh MB Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008, 1:CD002244.
13. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997, 99:226-231.
14. Karande S, Gupta V, Kulkarni M, Joshi A Prognostic clinical variables in childhood tuberculous meningitis: an experience from Mumbai, India. Neurol India 2005, 53:191-196.
15. Kumar R, Dwivedi A, Kumar P, Kohli N Tuberculous meningitis in BCG vaccinated and unvaccinated children. J Neurol Neurosurg Psychiatry 2005, 76:1550-1554.
16. Hamza T, van Houwelingen H, Stijnen T The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemiol 2008, 61:41-51.
17. Van Well GT, Paes BF, Terwee CB, et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the Western Cape of South Africa. Pediatrics 2009, 123:e1-e8.
18. Thwaites GE, Bang ND, Dung NH, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004, 351:1741-1751.
19. Wickham H ggplot2: elegant graphics for data analysis 2009, Springer, New York, NY.
20. Agarwal VK, Kumar P A follow up study of treated cases of tuberculous meningitis. Indian Pediatr 1969, 6:291-295.
21. Sumaya CV, Simek M, Smith MHD, Seidemann MF, Ferriss GS, Rubin W Tuberculous meningitis in children during the isoniazid era. J Pediatr 1975, 87:43-49.
22. Sunakorn P, Wongsaroj P Rifampin in treatment of tuberculous meningitis in children. J Med Assoc Thai 1978, 61:93-98.
23. Visudhiphan P, Chiemchanya S Hydrocephalus in tuberculous meningitis in children: treatment with acetazolamide and repeated lumbar puncture. J Pediatr 1979, 95:657-660.
24. Sunakorn P, Pongparit S, Wongrung S Short course chemotherapy in tuberculous meningitis. J Med Assoc Thai 1980, 63:340-345.
25. Frontera Izquierdo P, Calvo Rigual F, Tomás Vila M, Pérez Tamarit D, Monfort Martí A Meningitis tuberculosa en niños: estudio de 34 casos. An Esp Pediatr 1981, 14:311-320. (in Spanish).
26. Visudhiphan P, Chiemchanya S Tuberculous meningitis in children: treatment with isoniazid and rifampicin for twelve months. J Pediatr 1989, 114:875-879.
27. Jacobs RF, Sunakorn P, Chotpitayasunonah T, Pope S, Kelleher K Intensive short course chemotherapy for tuberculous meningitis. Pediatr Infect Dis J 1992, 11:194-198.
28. Shian WJ, Chi CS Central nervous system tuberculosis in infants and children. Zhonghua Yi Xue Za Zhi (Taipei) 1993, 52:391-397.
29. Doerr CA, Starke JR, Ong LT Clinical and public health aspects of tuberculous meningitis in children. J Pediatr 1995, 127:27-33.
30. Thilothammal N, Krishnamurthy PV, Banu K, Ratnam SR Tuberculous meningitis in children-clinical profile, mortality and morbidity of bacteriologically confirmed cases. Indian Pediatr 1995, 32:641-647.
31. Yaramis A, Gurkan F, Elevi M, et al. Central nervous system tuberculosis in children: a review of 214 cases. Pediatrics 1998, 102:e49-e53.
32. Paganini H, Gonzalez F, Santander C, Casimir L, Berberian G, Rosanova MT Tuberculous meningitis in children: clinical features and outcome in 40 cases. Scand J Infect Dis 2000, 32:41-45.
33. Tung YR, Lai MC, Lui CC, et al. Tuberculosis meningitis in infancy. Pediatr Neurol 2002, 27:262-266.
34. Degefie T Tuberculous meningitis in a district hospital from southern Ethiopia. Ethiop Med J 2003, 41:311-318.
35. Tinsa F, Essaddam L, Fitouri Z, Boussetta K, Becher SB, Bousnina S Central nervous system tuberculosis in infants. J Child Neurol 2010, 25:102-106.
36. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2003, 3:633-643.
37. Solomons RS, van Elsland SL, Visser DH, et al. Commercial nucleic acid amplification tests in tuberculous meningitis-a meta-analysis. Diag Microbiol Infect Dis 2014, 78:398-403.
38. Nhu NT, Heemskerk D, Thu do DA, et al. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol 2014, 52:226-233.
39. Patel VB, Theron G, Lenders L, et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med 2013, 10:e1001536.r.
40. Thwaites GE, van Toorn R, Schoeman J Tuberculous meningitis: more questions, still too few answers. Lancet Neurol 2013, 12:999-1010.
41. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of Bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995, 96:29-35.
42. Trunz BB, Fine PEM, Dye C Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006, 367:1173-1180.
43. Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 2010, 10:803-812.
44. Hristea A, Olaru ID Applying a consensus case definition to patients with confirmed tuberculous meningitis. Int J Infect Dis 2012, 16:e758-e759.
45. Ruslami R, Ganiem AR, Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis 2013, 13:27-35.
46. Seddon JA, Visser DH, Bartens M, et al. Impact of drug resistance on clinical outcome in children with tuberculous meningitis. Pediatr Infect Dis J 2012, 31:711-716.
47. Shah I, Meshram L High dose versus low dose steroids in children with tuberculous meningitis. J Clin Neurosci 2014, 21:761-764.